Skip to content

To study and compare intercostal nerve block versus nephrostomy tract infiltration for post operative analgesia after tubeless Percutaneous nephrolithotomy

Comparison of intercostal nerve block versus nephrostomy tract infiltration for post operative analgesia after tubeless Percutaneous nephrolithotomy

Status
Active, not recruiting
Phases
Phase 3Phase 4
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/05/052355
Enrollment
70
Registered
2023-05-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N200- Calculus of kidney

Interventions

Intervention1: intercoastal nerve block: intercostal nerve blockade along 10, 11 and 12th intercostal spaces with 0.5% ropivacaine 5 ml in each space. Interventions will be performed under fluoroscopi

Sponsors

department of anaesthesiology and critical care
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients aged between 18-60 years of either sex, belonging to American Society of Anesthesiologists (ASA) physical status (I and II) scheduled to undergo tubeless percutaneous nephrolithotomy under spinal anaesthesia for a single renal stone of >2cm diameter and requiring single subcostal puncture will be included in this study.

Exclusion criteria

Exclusion criteria: Contraindications to spinal anaesthesia such as coagulopathy infection at the site of lumbar puncture Known history of hypersensitivity/anaphylaxis/ contraindications to ropivacaine or its components Pregnancy Mental disorders/illness Excessive intraoperative bleeding More than one puncture and requiring supra-costal puncture ,BMI >30kgm-2 Chronic drug/analgesic abuse Refusal to give consent Surgical procedure >3hrs will be excluded from the study

Design outcomes

Primary

MeasureTime frame
To compare post operative visual analogue scale(VAS) following PTI versus ICNB with ropivacaine in patients undergoing tubelessPCNLTimepoint: recovery room 0 hrs 2hrs 4hrs 6hrs 24hrs

Secondary

MeasureTime frame
Change in hemodynamics and respiratory parametersTimepoint: Change in hemodynamics and respiratory parameters;Duration of post operative analgesiaTimepoint: Duration of post operative analgesia;Dynamic visual analogue scale (DVAS) Timepoint: recovery room 0 hrs 2hrs 4hrs 6hrs 24hrs;Mean number of doses and total analgesic consumption in 24 hoursTimepoint: Mean number of doses and total analgesic consumption in 24 hours;Side effects, if anyTimepoint: Side effects, if any

Countries

India

Contacts

Public ContactMadhuri garg

Pt BD Sharma PGIMS Rohtak

Dr.madhurigarg96@gmail.com8699493877

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026